N
OCDX

Nuveen’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Nuveen’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,508,783
Closed -$28.2M – 3615
2022
Q1 		$28.2M Sell
1,508,783
-109,960
-7% -$1.98M 0.01% 969
2021
Q4 		$34.6M Buy
1,618,743
+329,445
+26% +$6.49M 0.01% 899
2021
Q3 		$23.8M Buy
1,289,298
+392,764
+44% +$7.91M 0.01% 1152
2021
Q2 		$6.45M Buy
896,534
+13,852
+2% +$282K ﹤0.01% 2110
2021
Q1 		$17M Buy
+882,682
New +$15.6M 0.01% 1449

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nuveen's OCDX Position: Q2 2022 in Review

Nuveen sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 1,508,783 shares — an estimated $28.2M sold.

Nuveen first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $34.6M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Nuveen reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 1,508,783 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $28.2M.
  • Nuveen first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • Nuveen's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $34.6M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.